Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00117078
Status:
COMPLETED
Last Update Posted:
2008-09-30
First Post:
2005-06-30
Brief Title:
Aranesp Monthly Preference Study - 2
Sponsor:
Amgen
Organization:
Amgen
Study Overview
Official Title:
Aranesp Monthly Preference Study - 2
Status:
COMPLETED
Status Verified Date:
2008-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study was to evaluate subject preference for Aranesp administered once monthly ie every 4 weeks Q4W or Procrit administered once weekly QW
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None